Artemis Medicare to add 200+ beds in Gurugram, invest ₹160-180 Cr.
Artemis Medicare Services Limited will add over 200 beds to its Gurugram hospital in Tower IV. The expansion, costing ₹160-180 Crore, is expected within two years. This aims to boost quaternary pediatric and women's health services. The company also announced its Q1 FY27 financial results.
The expansion plan involves a substantial investment and addition of beds, which is expected to positively impact future revenue and market position. The financial results also provide an update on the company's performance.
The company is undertaking a significant capacity expansion and reporting financial results, indicating growth and operational progress.
Artemis Medicare Services Limited announced the approval of its expansion plan for Tower IV at its flagship hospital in Gurugram. The Board of Directors, in a meeting held on August 3, 2026, sanctioned the addition of over 200 beds, focusing on quaternary pediatric care and advanced gynecology & women's health services.
The expansion is expected to be completed within approximately two years and will require an investment of ₹160-180 Crore, to be financed through internal accruals and debt. This strategic move aims to meet the growing demand for specialized quaternary healthcare services in the Delhi NCR region and support long-term revenue growth.
In addition to the expansion, the company also announced its un-audited financial results for the quarter ended June 30, 2026. The financial results, both standalone and consolidated, were reviewed by the Audit Committee and approved by the Board. The full financial results are available on the websites of NSE, BSE, and the company's own website.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.